APA (7th ed.) Citation

Szachniewicz, M., van den Eeden, S., van Meijgaarden, K., Franken, K., van Veen, S., Geluk, A., . . . Ottenhoff, T. (2025). Intradermal versus subcutaneous immunization: Effects of administration route using a lipid-PLGA hybrid nanoparticle tuberculosis vaccine. European journal of pharmaceutical sciences, 205, 106995. https://doi.org/10.1016/j.ejps.2024.106995

Chicago Style (17th ed.) Citation

Szachniewicz, M.M, S.J.F van den Eeden, K.E van Meijgaarden, K.L.M.C Franken, S. van Veen, A. Geluk, J.A Bouwstra, and T.H.M Ottenhoff. "Intradermal Versus Subcutaneous Immunization: Effects of Administration Route Using a Lipid-PLGA Hybrid Nanoparticle Tuberculosis Vaccine." European Journal of Pharmaceutical Sciences 205 (2025): 106995. https://doi.org/10.1016/j.ejps.2024.106995.

MLA (9th ed.) Citation

Szachniewicz, M.M, et al. "Intradermal Versus Subcutaneous Immunization: Effects of Administration Route Using a Lipid-PLGA Hybrid Nanoparticle Tuberculosis Vaccine." European Journal of Pharmaceutical Sciences, vol. 205, 2025, p. 106995, https://doi.org/10.1016/j.ejps.2024.106995.